Abeona Therapeutics price to sales ratio ABEO

Market value divided by revenue over the last twelve months, since 2012.

Today, Oct 23, 2026: 9.9×
10-year median: 58.6×
Against its 10-year history: 0th; percentile: 0 is its lowest day, 100 its highest
10-year range: 9.9× to 196×
Peer median: 1.4×

Abeona Therapeutics' price to sales ratio is 9.9× as of Oct 23, 2026.

That is below its ten-year median of 58.6×, lower than on 100% of days in the last ten years.

Over that time it ranged from 9.9× in Oct 2026 to 196× in Nov 2016.

The median for 10 large drugmakers of a similar size is 1.4×.

Price to sales ratio over time

median 58.6×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	9.9×	9.9×	28.4×
2025	n/m a value too high to mean anything
2024	n/m a value too high to mean anything
2023	41.7×	34.9×	66.0×
2022	n/m a value too high to mean anything
2021	n/m a value too high to mean anything
2020	n/m a value too high to mean anything
2019	68.9×	58.1×	73.2×
2018	63.0×	58.7×	195×
2017	n/m a value too high to mean anything
2016	196×	74.0×	196×
2015	104×	1.8×	199×
2014	2.3×	2.3×	12.0×
2013	2.3×	1.5×	3.7×
2012	1.5×	1.4×	6.0×

Against its peers

Companies in Drug Manufacturers - General nearest Abeona Therapeutics' size, closest first, today.

Company	Price to sales ratio
ABEOAbeona Therapeutics	9.9×
NATRNatures Sunshine Products	0.4×
ARVNArvinas	1.5×
PBYIPuma Biotechnology	2.5×
IRWDIronwood Pharmaceuticals	1.5×
ZVRAZevra Therapeutics	4.3×
CRMDCorMedix	1.3×
COLLCollegium Pharmaceutical	0.9×
ABUSArbutus Biopharma	4.6×
LFVNLifevantage	0.4×
SPROSpero Therapeutics	1.4×
Peer median	1.4×

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Abeona Therapeutics

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.